APA (7th ed.) Citation

Nayankumar H. Patel, Jigna K. Padhiyar, Jahnvi R. Patel, & Keval V. Pandya. (2024). Favorable Response to Adjuvant Tofacitinib in a Case of Anti-Melanoma Differentiation-Associated Gene-5 Antibody Positive Clinically Amyopathic Dermatomyositis. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Nayankumar H. Patel, Jigna K. Padhiyar, Jahnvi R. Patel, and Keval V. Pandya. Favorable Response to Adjuvant Tofacitinib in a Case of Anti-Melanoma Differentiation-Associated Gene-5 Antibody Positive Clinically Amyopathic Dermatomyositis. Wolters Kluwer Medknow Publications, 2024.

MLA (9th ed.) Citation

Nayankumar H. Patel, et al. Favorable Response to Adjuvant Tofacitinib in a Case of Anti-Melanoma Differentiation-Associated Gene-5 Antibody Positive Clinically Amyopathic Dermatomyositis. Wolters Kluwer Medknow Publications, 2024.